The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zirtek 1 mg/ml oral solution

UCB (Pharma) Ireland LimitedPA0891/008/003

Main Information

Trade NameZirtek 1 mg/ml oral solution
Active SubstancesCetirizine dihydrochloride
Dosage FormOral solution
Licence HolderUCB (Pharma) Ireland Limited
Licence NumberPA0891/008/003

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE07 cetirizine


License statusAuthorised
Licence Issued26/03/1993
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicencePack sizes larger than 200 mls are subject to prescription. Promotion to the public for pack sizes of 200 ml or less. Promotion to Healthcare professionals for pack sizes larger than 200 ml.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back